Document is current
Any future updates will be listed below
-
Authors
Lalla-Edward, Samanta Tresha https://orcid.org/0000-0003-3597-1643
Venter, Willem Daniel Francois
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-037064)
Bill and Melinda Gates Foundation (INV-037064)
University of the Witwatersrand
- License Information
-
More Information
Article History
Accepted: 7 October 2024
First Online: 16 November 2024
Declarations
:
: Francois Venter declares receiving lecture fees and travel support from Roche, grant support, advisory board fees, and provision of drugs from Gilead Sciences, advisory board fees from ViiV Healthcare, lecture fees from Merck and Adcock Ingram, and lecture fees and advisory board fees from Johnson & Johnson and Mylan.
: This article does not contain any studies with human or animal subjects performed by any of the authors .
